Options Medical Weight Loss review
The only semaglutide figure is a twelve-month plan paid in full, so no monthly rate exists to rank at all.
The verdict
Options Medical Weight Loss states its semaglutide figure as $199 per month for a twelve-month plan paid in full — $2,388 charged at signup. No monthly rate is published, so no semaglutide price is ranked here. Tirzepatide is $299.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Options Medical Weight Loss sells both molecules by injection on annual plans, with higher tiers on the tirzepatide line and eligibility for health-account spending stated.
Who writes the prescription, and what do they see?
A prescription precedes dispensing and the clinician is not described. The commitment being annual makes that gap larger: a buyer is committing a year before meeting whoever will manage it.
The seller states the term twice on its own pages, which is more than many do, and it does not offer the alternative at all. A reader who wants to try a month cannot, at any price, because no month-to-month figure exists to quote.
What happens when the dose goes up?
Nothing states what the figure does at a higher dose on the semaglutide line. Tirzepatide is published as a band from $339 to $399 with the same twelve-month structure, so the ladder there is at least bounded.
What the price includes
$2,388 is the number to plan against on the semaglutide line, and it lands at once. The $199 monthly framing describes how that total divides rather than how it is billed, which is why no monthly figure is ranked for it here. Tirzepatide is the line that carries a rankable price: $299 a month, down from $399, with higher tiers previously published at $339 to $399. Health-account eligibility is stated, which helps with the tax treatment and not with the cash flow.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: The twelve-month term is stated on two pages
- Strength: HSA and FSA eligibility is published
- Strength: The tirzepatide band is bounded
- Strength: Tirzepatide fell $100
- Limitation: The whole year is charged at signup
- Limitation: No month-to-month rate is published
- Limitation: The monthly framing is arithmetic, not billing
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Options Medical Weight Loss. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader certain of a year who can pay $2,388 at once.
- Wrong for
- A reader who wants to start with one month.
The evidence behind what Options Medical Weight Loss prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Options Medical Weight Loss compares
| Seller | Who it suits | Go |
|---|---|---|
 Ozari Health | A reader new to the drug class who will check the plan table before quarter two | See Ozari Health → |
 Oria Meds | Readers who will commit six months and know which rung the headline is | See Oria Meds → |
 Oak | Readers who want a flat rate without a subscription and ignore the entry figure | See Oak → |
More GLP-1 telehealth sellers reviews: Defy MedicalDocberryElara MDEmbraceRXeMedEnara Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $199 billed monthly?
- No. Two of the seller's own pages state it is per month for a twelve-month plan paid in full, which is $2,388 charged at signup.
- Can I pay month to month?
- No month-to-month rate is published anywhere on the site.
- What does tirzepatide cost?
- $299 a month, down from $399, with higher tiers previously published between $339 and $399.